Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 30

1.

Immune Reconstitution Inflammatory Syndrome Unmasking or Worsening AIDS-Related Progressive Multifocal Leukoencephalopathy: A Literature Review.

Fournier A, Martin-Blondel G, Lechapt-Zalcman E, Dina J, Kazemi A, Verdon R, Mortier E, de La Blanchardière A.

Front Immunol. 2017 May 23;8:577. doi: 10.3389/fimmu.2017.00577. eCollection 2017. Review.

2.

Progressive multi-focal leucoencephalopathy - driven from rarity to clinical mainstream by iatrogenic immunodeficiency.

Misbah SA.

Clin Exp Immunol. 2017 Jun;188(3):342-352. doi: 10.1111/cei.12948. Epub 2017 Mar 27. Review.

PMID:
28245526
3.

Interleukin-7 treatment of PML in a patient with idiopathic lymphocytopenia.

Miskin DP, Chalkias SG, Dang X, Bord E, Batson S, Koralnik IJ.

Neurol Neuroimmunol Neuroinflamm. 2016 Mar 21;3(2):e213. doi: 10.1212/NXI.0000000000000213. eCollection 2016 Apr.

4.

Natalizumab-induced POU2AF1/Spi-B upregulation: A possible route for PML development.

Meira M, Sievers C, Hoffmann F, Haghikia A, Rasenack M, Décard BF, Kuhle J, Derfuss T, Kappos L, Lindberg RL.

Neurol Neuroimmunol Neuroinflamm. 2016 Mar 31;3(3):e223. doi: 10.1212/NXI.0000000000000223. eCollection 2016 Jun.

5.

Type I Interferons Regulate the Magnitude and Functionality of Mouse Polyomavirus-Specific CD8 T Cells in a Virus Strain-Dependent Manner.

Qin Q, Shwetank, Frost EL, Maru S, Lukacher AE.

J Virol. 2016 Apr 29;90(10):5187-99. doi: 10.1128/JVI.00199-16. Print 2016 May 15.

6.

Predictors and characteristics of seizures in survivors of progressive multifocal leukoencephalopathy.

Miskin DP, Herman ST, Ngo LH, Koralnik IJ.

J Neurovirol. 2016 Aug;22(4):464-71. doi: 10.1007/s13365-015-0414-3. Epub 2015 Dec 16.

PMID:
26676826
7.

Broadly neutralizing human monoclonal JC polyomavirus VP1-specific antibodies as candidate therapeutics for progressive multifocal leukoencephalopathy.

Jelcic I, Combaluzier B, Jelcic I, Faigle W, Senn L, Reinhart BJ, Ströh L, Nitsch RM, Stehle T, Sospedra M, Grimm J, Martin R.

Sci Transl Med. 2015 Sep 23;7(306):306ra150. doi: 10.1126/scitranslmed.aac8691. Epub 2015 Sep 23.

8.

Brief Report: Role of Thymic Reconstitution in the Outcome of AIDS-Related PML.

Chalkias SG, Gheuens S, Bord E, Batson S, Koralnik IJ.

J Acquir Immune Defic Syndr. 2015 Dec 1;70(4):357-61. doi: 10.1097/QAI.0000000000000754.

9.

Progressive neurologic dysfunction in a psoriasis patient treated with dimethyl fumarate.

Bartsch T, Rempe T, Wrede A, Leypoldt F, Brück W, Adams O, Rohr A, Jansen O, Wüthrich C, Deuschl G, Koralnik IJ.

Ann Neurol. 2015 Oct;78(4):501-14. doi: 10.1002/ana.24471. Epub 2015 Jul 31. Review.

10.
11.
12.

Predictors of survival and functional outcomes in natalizumab-associated progressive multifocal leukoencephalopathy.

Dong-Si T, Gheuens S, Gangadharan A, Wenten M, Philip J, McIninch J, Datta S, Richert N, Bozic C, Bloomgren G, Richman S, Weber T, Clifford DB.

J Neurovirol. 2015 Dec;21(6):637-44. doi: 10.1007/s13365-015-0316-4. Epub 2015 Mar 14.

13.

Treating progressive multifocal leukoencephalopathy with interleukin 7 and vaccination with JC virus capsid protein VP1.

Sospedra M, Schippling S, Yousef S, Jelcic I, Bofill-Mas S, Planas R, Stellmann JP, Demina V, Cinque P, Garcea R, Croughs T, Girones R, Martin R.

Clin Infect Dis. 2014 Dec 1;59(11):1588-92. doi: 10.1093/cid/ciu682. Epub 2014 Sep 11.

14.

JCV GCN in a natalizumab-treated MS patient is associated with mutations of the VP1 capsid gene.

Agnihotri SP, Dang X, Carter JL, Fife TD, Bord E, Batson S, Koralnik IJ.

Neurology. 2014 Aug 19;83(8):727-32. doi: 10.1212/WNL.0000000000000713. Epub 2014 Jul 18.

15.

A fatal case of JC virus meningitis presenting with hydrocephalus in a human immunodeficiency virus-seronegative patient.

Agnihotri SP, Wuthrich C, Dang X, Nauen D, Karimi R, Viscidi R, Bord E, Batson S, Troncoso J, Koralnik IJ.

Ann Neurol. 2014 Jul;76(1):140-7. doi: 10.1002/ana.24192. Epub 2014 Jun 20.

16.

Progressive multifocal leukoencephalopathy in a 62-year-old immunocompetent woman.

Gourineni VC, Juvet T, Kumar Y, Bordea D, Sena KN.

Case Rep Neurol Med. 2014;2014:549271. doi: 10.1155/2014/549271. Epub 2014 Feb 23.

17.

JC virus reactivation during prolonged natalizumab monotherapy for multiple sclerosis.

Chalkias S, Dang X, Bord E, Stein MC, Kinkel RP, Sloane JA, Donnelly M, Ionete C, Houtchens MK, Buckle GJ, Batson S, Koralnik IJ.

Ann Neurol. 2014 Jun;75(6):925-34. doi: 10.1002/ana.24148. Epub 2014 Jun 10.

18.

Immune reconstitution after allogeneic hematopoietic stem cell transplantation is associated with selective control of JC virus reactivation.

Tan CS, Broge TA Jr, Ngo L, Gheuens S, Viscidi R, Bord E, Rosenblatt J, Wong M, Avigan D, Koralnik IJ.

Biol Blood Marrow Transplant. 2014 Jul;20(7):992-9. doi: 10.1016/j.bbmt.2014.03.018. Epub 2014 Mar 27.

19.

Reactivation of human polyomaviruses in immunocompromised states.

Wiedinger K, Bitsaktsis C, Chang S.

J Neurovirol. 2014 Feb;20(1):1-8. doi: 10.1007/s13365-014-0234-x. Epub 2014 Jan 31.

20.

The role of the immune response in merkel cell carcinoma.

Triozzi PL, Fernandez AP.

Cancers (Basel). 2013 Feb 28;5(1):234-54. doi: 10.3390/cancers5010234.

Supplemental Content

Support Center